By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Amgen 

Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010


SEARCH JOBS

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit
www.amgen.com, LinkedIn and follow us on www.twitter.com/amgen.

FOLLOW AMGEN:





Key Statistics


Email:
Ownership: Public

Web Site: Amgen
Employees: 20,000
Symbol: AMGN
 









Company News
Amgen (AMGN) Goes on the Defensive When Critics Call Its Pipeline a Dud 6/22/2017 6:11:48 AM
Amgen (AMGN) To Present New Data At 22nd Congress Of The European Hematology Association 6/21/2017 10:01:17 AM
FDA Accepts Amgen (AMGN)'s Supplemental Biologics License Application To Expand Indication For XGEVA (Denosumab) To Include Multiple Myeloma Patients 6/19/2017 7:38:52 AM
While Amgen (AMGN)-Size Biotechs Run Into Trouble, These Are The Biotechs With The Most Promising Pipelines 6/16/2017 6:43:54 AM
Life Sciences Professionals Name Top 30 Ideal Employers 6/15/2017 10:43:10 AM
Landmark Ruling: Amgen (AMGN) Loses Bid to Delay Biosimilars 6/13/2017 6:07:04 AM
Bay Area's Coherus Craters After the FDA Spurns Its Biosimilar for Amgen (AMGN)'s Neulasta 6/12/2017 5:54:54 AM
Amgen (AMGN) Presents Erenumab Data At The 59th Annual Scientific Meeting of the American Headache Society 6/9/2017 6:37:45 AM
How This Small Washington Biotech Stands To Outperform Rivals Amgen (AMGN), Eli Lilly (LLY) And Teva (TEVA) In Migraine Drugs 6/9/2017 6:04:01 AM
Amgen (AMGN) And Allergan (AGN) Announce FDA Advisory Committee Meeting To Review ABP 215, A Biosimilar Candidate To Bevacizumab 6/7/2017 10:13:45 AM
12345678910...
//-->